372320 — Curocell Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩445bn
- KR₩456bn
Annual cashflow statement for Curocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | — | — | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | — | -53,576 | -38,885 | -29,575 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | — | 41,448 | 21,109 | 372 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -6,885 | -1,123 | 1,557 | -767 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -6,885 | -11,536 | -14,392 | -25,264 |
| Capital Expenditures | -3,577 | -9,299 | -27,870 | -21,650 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -30,643 | 17,794 | -12,851 | 524 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -34,220 | 8,495 | -40,721 | -21,127 |
| Financing Cash Flow Items | — | -18.2 | — | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 43,666 | 42,224 | 19,148 | 49,682 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 2,561 | 39,183 | -35,964 | 3,291 |